23-25 The FDA-approved indication for weight management use of GLP-1 RAs is a BMI of 30 or higher, or a BMI of 27 or higher with at least 1 other cardiometabolic comorbidity such as type 2 diabetes or hyperlipidemia
Let your doctor know you are taking Ozempic, Wegovy or Mounjaro and describe your symptoms, when they started and if they are getting worse
Ozempics warning label mentions risks of thyroid tumors
When these habits are in place, you might stop treatment with only a slight risk of setbacks
Aunque es poco comn, la semaglutida puede provocar reacciones alrgicas
Weighing yourself every morning can lead to confusion, as water retention, digestion, and hormonal changes can cause daily ups and downs that mask real trends